[HTML][HTML] Justificativa e Desenho do Ensaio Clínico Randomizado COVID-19 Outpatient Prevention Evaluation (COPE-Coalition V): Hidroxicloroquina vs. Placebo em …
HA Oliveira, CP Ferri, I Boszczowski… - Arquivos Brasileiros …, 2022 - SciELO Brasil
Fundamento Apesar da necessidade de opções terapêuticas específicas para a doença do
coronavírus 2019 (covid-19), ainda não há evidências da eficácia de tratamentos …
coronavírus 2019 (covid-19), ainda não há evidências da eficácia de tratamentos …
[PDF][PDF] A Prospective Randomized Controlled Trial: Short-Time In Vitro Maturation For Improvement of Oocytes Quality And Reproductive Outcomes
Y Liu, Y Shi, H Zeng, C Fang, R Chian, X Liang - 2022 - pdfs.semanticscholar.org
Background: Current standard stimulation protocols use gonadotropins (recombinant or
hMG) combined with LHRH agonists to prevent premature ovulation to obtain an average of …
hMG) combined with LHRH agonists to prevent premature ovulation to obtain an average of …
Extending the multi-arm multi-stage trial design
AM Blenkinsop - 2020 - discovery.ucl.ac.uk
The multi-arm multi-stage (MAMS) adaptive clinical trial design has been successfully
implemented in several randomised phase III trials. Intermediate short-term outcomes …
implemented in several randomised phase III trials. Intermediate short-term outcomes …
[HTML][HTML] Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE–Coalition COVID-19 …
GBF Oliveira, PDMM Neves, HA Oliveira… - Arquivos Brasileiros …, 2023 - SciELO Brasil
Fundamento Estudos anteriores revelaram alto risco de eventos tromboembólicos arteriais
e venosos como consequência de danos virais diretos do SARS-CoV-2 em células …
e venosos como consequência de danos virais diretos do SARS-CoV-2 em células …
[PDF][PDF] COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial
LCP de Azevedo, RD Cutait - cdn.clinicaltrials.gov
Methods: This is a pragmatic, prospective, randomized, stratified, multicenter, open-label,
controlled trial including 350 patients with earlyonset (less than 48 hours before …
controlled trial including 350 patients with earlyonset (less than 48 hours before …
[PDF][PDF] Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The …
RPDC Sirio-Libanes - 2020 - c-mep.net.br
OBJECTIVE To determine whether intravenous dexamethasone increases the number of
ventilator-free days among patients with COVID-19–associated ARDS. DESIGN, SETTING …
ventilator-free days among patients with COVID-19–associated ARDS. DESIGN, SETTING …